Related references
Note: Only part of the references are listed.Effects of polaprezinc on gastric mucosal damage and neurotransmitters in a rat model of chemotherapy-induced vomiting
Zhao Yang Liu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2018)
Antioxidant, Anti-inflammatory, and Genomic Stability Enhancement Effects of Zinc l-carnosine: A Potential Cancer Chemopreventive Agent?
Theng Choon Ooi et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2017)
Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: Multicenter randomized trial
Yashiro Yoshizawa et al.
DIGESTIVE ENDOSCOPY (2016)
Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy
Kazuhiko Nakamura et al.
GUT AND LIVER (2016)
Proper muscle layer damage affects ulcer healing after gastric endoscopic submucosal dissection
Yohei Horikawa et al.
DIGESTIVE ENDOSCOPY (2015)
Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice
Masahiro Murakami-Nakayama et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Risk factors of delayed ulcer healing after gastric endoscopic submucosal dissection
Joo Hyun Lim et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2015)
Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study
Kazuhide Higuchi et al.
GASTRIC CANCER (2015)
Efficacy and Safety of Proton Pump Inhibitors (PPIs) Plus Rebamipide for Endoscopic Submucosal Dissection-induced Ulcers: A Meta-analysis
Jun Wang et al.
INTERNAL MEDICINE (2014)
Comparison of the efficacy of 4-and 8-week lansoprazole treatment for ESD-induced gastric ulcers: a randomized, prospective, controlled study
Ji Hoon Park et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2014)
Two-week treatment with proton pump inhibitor is sufficient for healing post endoscopic submucosal dissection ulcers
Makoto Arai et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: Comparison study with rebamipide
Hyuk Soon Choi et al.
LIFE SCIENCES (2013)
Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study
Woon Geon Shin et al.
GASTROINTESTINAL ENDOSCOPY (2012)
Combination of proton pump inhibitor and rebamipide, a free radical scavenger, promotes artificial ulcer healing after endoscopic submucosal dissection with dissection size >40 mm
Hiroshi Araki et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2012)
Proton Pump Inhibitor Dose-Related Healing Rate of Artificial Ulcers after Endoscopic Submucosal Dissection: A Prospective Randomized Controlled Trial
Seiji Kawano et al.
DIGESTION (2011)
Risk factors for delayed bleeding after endoscopic submucosal dissection for gastric neoplasm
Kazuhisa Okada et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2011)
Rebamipide: a gastrointestinal protective drug with pleiotropic activities
Yuji Naito et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Zinc L-carnosine protects against mucosal injury in portal hypertensive gastropathy through induction of heat shock protein 72
Ken-Ichiro Mikami et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Expression of HSP72 in the gastric mucosa is regulated by gastric acid in rats - Correlation of HSP72 expression with mucosal protection
Isao Wada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Share Paper
